Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

We have observed 5 EP applications Marie-Line Tinel has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after June 24, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12305479

Semuloparin for improving the survival of patients with cancer

IPC classification:
A61P 7/02, A61P 35/00, A61K 31/00, A61K 31/727
Applicant:
Aventis Pharma S.A.
Agent:
Marie-Line Tinel, Sanofi
Status:
APPLICATION REFUSED
EP13714652

AN H3 RECEPTOR ANTAGONIST FOR USE IN THE TREATMENT OF ALZHEIMER'S DISEASE

IPC classification:
A61K 31/4725, A61P 25/28
Applicant:
Sanofi, S.A.
Agent:
Marie-Line Tinel, Sanofi
Status:
PATENT GRANTED
EP13805299

PROCESS FOR PREPARING 4-(CYCLOPROPYLMETHOXY)-N-(3,5-DICHLORO-1-OXIDO-4-PYRIDYL)-5-METHOXYPYRIDINE-2-CARBOXAMIDE

IPC classification:
C07D 401/12, C07D 401/06, C07D 213/69
Applicant:
Sanofi, S.A.
Agent:
Nony, Cabinet Nony
Agent:
Marie-Line Tinel, Sanofi
Status:
GRANT OF PATENT INTENDED
EP13796087

METHOD OF PREPARATION OF CRYSTAL FORMS OF 4-(CYCLOPROPYLMETHOXY)-N-(3,5-DICHLORO-1-OXIDOPYRIDYN-4-yl)-5-METHOXYPYRIDINE-2-CARBOXAMIDE AND CRISTAL FORMS THEREOF

IPC classification:
A61K 31/4412, C07D 213/89, A61P 25/00
Applicant:
Sanofi, S.A.
Agent:
Cabinet Nony
Agent:
Marie-Line Tinel, Sanofi
Status:
EXAMINATION IN PROGRESS
EP16701353

ANTI-CD3 ANTIBODIES, ANTI-CD123 ANTIBODIES AND BISPECIFIC ANTIBODIES SPECIFICALLY BINDING TO CD3 AND/OR CD123

IPC classification:
A61K 39/00, C07K 16/28
Applicant:
Sanofi
Agent:
Marie-Line Tinel, Sanofi
Agent:
Cabinet Lavoix
Status:
Request for examination was made

Please Sign in to use this feature